Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dombernowsky

Showing results (31-40 of 211) with videos related to

Pageof 22
Sort By:
Cancer Treatment Reports|September 1, 1976
Phase II study of vinblastine, adriamycin, and procarbazine in small cell carcinoma of the lungS Sörenson, H H Hansen, P Dombernowsky
Clinical Chemistry and Laboratory Medicine|August 22, 2000
Assessment of CA 15.3, CEA and TPA concentrations during monitoring of breast cancerG Sölétormos, P H Petersen, P Dombernowsky
British Journal of Cancer|May 18, 2001
Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapyM K Tuxen, G Sölétormos, P Dombernowsky
Cell and Tissue Kinetics|January 1, 1974
Cytokinetic studies of the regenerative phase in the JB-1 ascites tumourP Dombernowsky, P Bichel, N R Hartmann
Cancer Treatment Reviews|May 1, 1995
Tumor markers in the management of patients with ovarian cancerM K Tuxen, G Sölétormos, P Dombernowsky
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Dose-limiting hypotension with the 5-HT3-antagonist batanopride (BMY-25801)J Herrstedt, B H Jeppesen, P Dombernowsky
JAMA|July 18, 1980
Long-term survival in small cell carcinoma of the lungM Hansen, H H Hansen, P Dombernowsky
Cell and Tissue Kinetics|July 1, 1973
Cytokinetic analysis of the JB-1 ascites tumour at different stages of growthP Dombernowsky, P Bichel, N R Hartmann
Scandinavian Journal of Clinical and Laboratory Investigation|June 29, 2002
Serum tumor marker CA 125 for monitoring ovarian cancer during follow-upM K Tuxen, G Sölétormos, P Dombernowsky
Clinical Chemistry|July 15, 2000
Progression criteria for cancer antigen 15.3 and carcinoembryonic antigen in metastatic breast cancer compared by computer simulation of marker dataG Sölétormos, P Hyltoft Petersen, P Dombernowsky
Pageof 22

Showing results (31-40 of 211) with videos related to

Sort By:
Pageof 22
Cancer Treatment Reports|September 1, 1976
Phase II study of vinblastine, adriamycin, and procarbazine in small cell carcinoma of the lungS Sörenson, H H Hansen, P Dombernowsky
Clinical Chemistry and Laboratory Medicine|August 22, 2000
Assessment of CA 15.3, CEA and TPA concentrations during monitoring of breast cancerG Sölétormos, P H Petersen, P Dombernowsky
British Journal of Cancer|May 18, 2001
Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapyM K Tuxen, G Sölétormos, P Dombernowsky
Cell and Tissue Kinetics|January 1, 1974
Cytokinetic studies of the regenerative phase in the JB-1 ascites tumourP Dombernowsky, P Bichel, N R Hartmann
Cancer Treatment Reviews|May 1, 1995
Tumor markers in the management of patients with ovarian cancerM K Tuxen, G Sölétormos, P Dombernowsky
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Dose-limiting hypotension with the 5-HT3-antagonist batanopride (BMY-25801)J Herrstedt, B H Jeppesen, P Dombernowsky
JAMA|July 18, 1980
Long-term survival in small cell carcinoma of the lungM Hansen, H H Hansen, P Dombernowsky
Cell and Tissue Kinetics|July 1, 1973
Cytokinetic analysis of the JB-1 ascites tumour at different stages of growthP Dombernowsky, P Bichel, N R Hartmann
Scandinavian Journal of Clinical and Laboratory Investigation|June 29, 2002
Serum tumor marker CA 125 for monitoring ovarian cancer during follow-upM K Tuxen, G Sölétormos, P Dombernowsky
Clinical Chemistry|July 15, 2000
Progression criteria for cancer antigen 15.3 and carcinoembryonic antigen in metastatic breast cancer compared by computer simulation of marker dataG Sölétormos, P Hyltoft Petersen, P Dombernowsky
Pageof 22